Thromboembolic disease in COVID-19 patients: A brief narrative review.
JournalJournal of intensive care
MetadataShow full item record
AbstractCorona virus 2 (SARS-CoV2/ Severe Acute Respiratory Syndrome Corona Virus 2) infection has emerged as a global health crisis. Incidence of thromboembolic disease is reported to be high in SARS-CoV2 disease and is seen in a multitude of organ systems ranging from cutaneous thrombosis to pulmonary embolism, stroke or coronary thrombosis sometimes with catastrophic outcomes. Evidence points towards a key role of thromboembolism, hypercoagulability and over production of proinflammatory cytokines mimicking a "cytokine storm"which leads to multiorgan failure. This brief narrative review highlights the pathophysiology and risk factors of thromboembolic disease and provides a framework for management of anticoagulation based on the current evidence.
Rights/Terms© The Author(s) 2020.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/13832
- Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
- Authors: Singh S, Zuwasti U, Haas C
- Issue date: 2020 Nov 3
- The looming storm: Blood and cytokines in COVID-19.
- Authors: Kaur S, Bansal R, Kollimuttathuillam S, Gowda AM, Singh B, Mehta D, Maroules M
- Issue date: 2020 Aug 18
- [COVID-19 infection-Risk of thromboembolic complications].
- Authors: Zerwes S, Steinbauer M, Gosslau Y, Warm T, Hyhlik-Dürr A
- Issue date: 2020 Sep 1
- Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
- Authors: Chibane S, Gibeau G, Poulin F, Tessier P, Goulet M, Carrier M, Lanthier S
- Issue date: 2020 Jun 6
- Utility of D-dimer as a Prognostic Factor in SARS CoV2 Infection: A Review.
- Authors: Kariyanna PT, Aurora L, Jayarangaiah A, Yadav V, Hossain NA, Akter N, Salifu MO, McFarlane IM
- Issue date: 2020